| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.29▲ | 1.31▼ | 1.33▼ | 1.42▼ | 1.61▼ |
| MA10 | 1.29▲ | 1.37▼ | 1.40▼ | 1.51▼ | 1.78▼ |
| MA20 | 1.32▼ | 1.42▼ | 1.44▼ | 1.62▼ | 2.10▼ |
| MA50 | 1.38▼ | 1.57▼ | 1.62▼ | 1.86▼ | 2.15▼ |
| MA100 | 1.49▼ | 1.66▼ | 1.69▼ | 2.14▼ | 3.06▼ |
| MA200 | 1.63▼ | 2.00▼ | 2.09▼ | 2.17▼ | 2.47▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | -0.008▼ | -0.012▼ | -0.021▼ | -0.088▼ |
| RSI | 29.574▼ | 21.087▼ | 19.091▼ | 24.599▼ | 31.240▼ |
| STOCH | 43.056 | 1.934▼ | 11.004▼ | 9.378▼ | 5.266▼ |
| WILL %R | -57.143 | -92.308▼ | -92.857▼ | -96.296▼ | -98.804▼ |
| CCI | -31.894 | -104.435▼ | -146.147▼ | -118.703▼ | -111.494▼ |
|
Tuesday, October 28, 2025 05:59 AM
(RTTNews) - Edesa Biotech, Inc. (EDSA), a clinical-stage biopharmaceutical company, on Tuesday reported positive results from a Phase 3 study evaluating paridiprubart, its drug candidate for the ...
|
|
Friday, December 13, 2024 01:40 PM
The company has successfully pivoted its anti-TLR4 drug candidate, EB05, to a U.S. government-funded study, indicating strong backing from governmental institutions and potential for further ...
|
|
Tuesday, October 31, 2023 05:00 PM
The average one-year price target for Edesa Biotech (NASDAQ:EDSA) has been revised to 53.38 / share. This is an increase of 528.00% from the prior estimate of 8.50 dated October 4, 2023. The price ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/12/25 | 1.41 | 1.42 | 1.28 | 1.30 | 66,800 |
| 23/12/25 | 1.46 | 1.49 | 1.38 | 1.39 | 32,300 |
| 22/12/25 | 1.48 | 1.50 | 1.46 | 1.46 | 10,200 |
| 19/12/25 | 1.43 | 1.48 | 1.43 | 1.48 | 26,800 |
| 18/12/25 | 1.52 | 1.53 | 1.47 | 1.47 | 22,000 |
| 17/12/25 | 1.48 | 1.54 | 1.48 | 1.52 | 20,800 |
| 16/12/25 | 1.46 | 1.49 | 1.45 | 1.49 | 33,200 |
| 15/12/25 | 1.69 | 1.705 | 1.44 | 1.46 | 89,809 |
| 12/12/25 | 1.75 | 1.76 | 1.7086 | 1.74 | 39,309 |
| 11/12/25 | 1.78 | 1.79 | 1.75 | 1.77 | 39,200 |
|
|
||||
|
|
||||
|
|